Ritten Raises $35M Series B for AI-Powered Behavioral Health EMR
Ritten

Get the full Ritten company profile
Access contacts, investors, buying signals & more
Ritten, a company specializing in Electronic Health Records (EHR) software for behavioral health, has announced it has secured $35,000,000 in new investment capital from a group of investors.
This significant funding round is set to bolster the company's operations and accelerate its strategic expansion within the healthcare technology sector.
The company provides an industry-first AI-Powered EMR/CRM/RCM platform specifically designed to meet the complex care requirements unique to behavioral health treatment facilities.
Ritten's software assists addiction treatment, mental health, and behavioral healthcare professionals across the full continuum of care, helping them drive referrals, streamline billing processes, and accurately measure patient outcomes.
This substantial investment not only validates Ritten's innovative approach but also underscores a growing market recognition of the critical need for specialized technological solutions in this evolving healthcare sector.
The newly raised capital is earmarked to accelerate Ritten's growth initiatives and further enhance its platform.
Plans include expanding the company's AI capabilities to refine its predictive analytics and automation features, developing additional platform functionalities, and scaling its market reach to serve a greater number of facilities and professionals nationwide.
This funding round is crucial for Ritten's ability to continue innovating and providing essential tools that improve operational efficiency and patient care quality in a highly specialized field.
The capital infusion will enable Ritten to deepen its commitment to addressing the unique challenges faced by behavioral health providers.
Looking ahead, Ritten aims to solidify its position as a leading technology provider in this vital segment of healthcare.
The company intends to leverage this investment to drive sustained product development and expand its footprint, ultimately supporting a broader network of healthcare providers in delivering effective and measurable treatment outcomes.
Buying Signals & Intent
Our AI suggests Ritten may be interested in:
Unlock GTM Signals
Discover Ritten's tech stack and active buying intent signals.
View GTM SignalsTrusted by 200+ sales professionals
Unlock Investor Data
See who invested in Ritten and connect with key investment contacts.
Unlock InvestorsTrusted by 200+ sales professionals
Unlock Key Decision-Makers
Get direct access to the key decision-makers at Ritten.
Unlock Decision-MakersTrusted by 200+ sales professionals